Barely Significant
← all excerpts

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.

Ann Oncol · 2018 · PMC6128180 · PMID 29905778

Europe PMCDOI
1
hedged sentence
0.1685
closest p · 3.4× alpha
0.1685
boldest claim

The sentences

did not reach statistical significanceP < 0.1685not close (p > 0.1)
Median OS was also improved, although this did not reach statistical significance [9.69 months with cetuximab versus 8.38 months in the taxane–carboplatin arm (HR = 0.89; 95% CI 0.75–1.05; P < 0.1685)].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.